Institute of Population Health
R. Samuel McLaughlin Centre for Population Health Risk Assessment


University of Ottawa
Knowledge Translation Workshop
Tabaret Hall, 550 Cumberland Street, Room 083

November 25-26, 2007
Knowledge Translation in the Post Market Evaluation
 of Drug Safety and Effectiveness Data

Get Final Program

KT workshop full report

KT workshop summary (English)

KT workshop summary (French)

Workshop participants

Sunday November 25, 2007

Workshop Objectives
Noralou Roos, University of Manitoba

Keynote speaker – Principles of Knowledge Translation
Jeremy Grimshaw, OHRI & University of Ottawa

Monday November 26, 2007

National Pharmaceutical Strategy (NPS) context
Abby Hoffman, Health Canada

Improving knowledge translation on medication harms and benefits
Anne Holbrook, McMaster University

Innovative approaches to fostering behavioural change
Lisa Dolovich, McMaster University

  • View Slides

Communicating with Health Professionals and the Public
Vicky Hogan, Health Canada

COMPUS – Early Experiences in KT – Evidence to Implementation
Bill Leslie, CADTH

James McCormack, University of British Columbia (UBC)

Panel Discussion «Knowledge Translation Needs in Communicating Drug Risks and Effectiveness in Canada»

Panel Chair: Noralou Roos, University of Manitoba

Panel Members:
Carol Repchinsky, Canadian Pharmacists Association (CPhA)

 Carol Kushner, Communications

Brent Fraser, Drug Plan Group, Ministry of Health and Long Term-Care, Ontario

Cindy Evans, Health Canada, Therapeutic Effectiveness and Policy Bureau, MHPD

 Judy Birdsell, Health Charities Volunteer

Madeline Boscoe, Patients/Public Group

Breakout groups “Strenghten the Role of Knowledge Translation (KT) in the Real-World Drug Safety and Effectiveness
Charge to breakout groups, Madeline Boscoe

Daniel Krewski, University of Ottawa

Online presentations from the KT Workshop are subject to copyright protection. Permission from the speaker is required prior to any copying, reproducing, or rebroadcasiting any portion of the speaker’s presentations.

The KT workshop was organized by a steering committee:

Workshop Steering Committee:
Barb Shea CADTH
Bill Leslie, CADTH
Brenda MacGibbon-Taylor, Patient representative. McGill University Health Centre
Chris Turner, Health Canada
Colleen Metge, University of Manitoba
Craig Larsen, CADTH
Daniel Krewski, University of Ottawa
Daniel Bedard, University of Ottawa
Ian Graham, CIHR
Ingrid Sketris, Dalhousie
Jean Gray, Professor Emeritus, Dalhousie
Judy Birdsell, On Management Health Group, Alberta
Lisa Dolovich, McMaster University
Madeline Boscoe, Canadian Women’s Health Network
Muhammad Mamdani, University of Toronto
Noralou Roos, University of Manitoba
Robyn Tamblyn, McGill University
Susanne Reid, Health Canada
Vicky Hogan, Health Canada
Wayne Lepine, Health Canada
Wayne Nitchuk Health Canada

Canadian Agency for Drugs and Technologies in Health (CADTH)
Canadian Health Services Research Foundation (CHSRF)
Canadian Institutes Health Research (CIHR)/IHSPR
Canadian Patient Safety Institute (CPSI)
Health Canada/National Pharmaceutical Strategy

Canadian Agency for Drugs and Technologies in Health (CADTH)
Canadian AIDS Treatment Information Exchange (CATIE)
Canadian Pharmacists Association (CPhA)
Canadian Women’s Health Network (CWHN)
Decision Support Tools (Annette O’Connor)
IMPACT Program (Lisa Dolovich)
MedEffect Program (Health Canada)
Therapeutics Initiative